Jones Financial Companies

Jones Financial Companies Portfolio holdings

AUM $164B
1-Year Est. Return 15.9%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+15.9%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$164B
AUM Growth
+$17.2B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,667
New
Increased
Reduced
Closed

Top Sells

1 +$538M
2 +$442M
3 +$118M
4
VTWO icon
Vanguard Russell 2000 ETF
VTWO
+$111M
5
EFA icon
iShares MSCI EAFE ETF
EFA
+$64.2M

Sector Composition

1 Technology 2.81%
2 Financials 1.17%
3 Consumer Discretionary 1.11%
4 Communication Services 0.99%
5 Healthcare 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USD icon
4501
ProShares Ultra Semiconductors
USD
$1.69B
-140
USDU icon
4502
WisdomTree Bloomberg US Dollar Bullish Fund
USDU
$185M
-113
UTES icon
4503
Virtus Reaves Utilities ETF
UTES
$1.44B
-332
VBTX
4504
DELISTED
Veritex Holdings
VBTX
-265
VCRB icon
4505
Vanguard Core Bond ETF
VCRB
$5.89B
0
VEGI icon
4506
iShares MSCI Agriculture Producers ETF
VEGI
$112M
-750
VGSR icon
4507
Vert Global Sustainable Real Estate ETF
VGSR
$487M
0
VNLA icon
4508
Janus Henderson Short Duration Income ETF
VNLA
$3.06B
-62
VRNA
4509
DELISTED
Verona Pharma
VRNA
-300
VRNT
4510
DELISTED
Verint Systems
VRNT
-383
VSTA
4511
DELISTED
Vasta Platform
VSTA
-4,000
VTLE
4512
DELISTED
Vital Energy
VTLE
-150
WNS
4513
DELISTED
WNS Holdings
WNS
-491
WTAI icon
4514
WisdomTree Artificial Intelligence and Innovation Fund
WTAI
$368M
-100
XFIV icon
4515
BondBloxx Bloomberg Five Year Target Duration US Treasury ETF
XFIV
$436M
-375
XPRO icon
4516
Expro
XPRO
$1.91B
-100
YYY icon
4517
Amplify CEF High Income ETF
YYY
$697M
-3,450
ZIMV
4518
DELISTED
ZimVie
ZIMV
-220
ZSC icon
4519
USCF Sustainable Commodity Strategy Fund
ZSC
$2.88M
0
ZTO icon
4520
ZTO Express
ZTO
$17.1B
-217
ZURA icon
4521
Zura Bio
ZURA
$641M
-1,369
ARQ icon
4522
Arq
ARQ
$145M
-50
GOLY icon
4523
Strategy Shares Gold-Hedged Bond ETF
GOLY
$181M
-47
AXIL
4524
AXIL Brands
AXIL
$44.1M
-350
CERO
4525
DELISTED
CERo Therapeutics
CERO
-3